These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1684341)

  • 1. [Multidrug resistance in lymphoproliferative syndromes].
    Damiani D; Michelutti A; Michieli M; Geromin A; Raspadori D; Giacca M; Mallardi F; Baccarani M
    Haematologica; 1991 Jun; 76 Suppl 3():162-4. PubMed ID: 1684341
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glycoprotein P-170, associated with multidrug resistance, in patients with acute leukemia in complete remission].
    Musto P; Carotenuto M
    Haematologica; 1991 Jun; 76 Suppl 3():169-72. PubMed ID: 1684343
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multidrug resistance in acute nonlymphoid leukemia].
    Michieli M; Geromin A; Damiani D; Michelutti A; Raspadori D; Masotti A; Russo D; Fanin R; Fasola G; Mallardi F
    Haematologica; 1991 Jun; 76 Suppl 3():165-8. PubMed ID: 1684342
    [No Abstract]   [Full Text] [Related]  

  • 4. [The MDR phenotype in acute nonlymphoid leukemia].
    Liso V; Specchia G; Pansini N; Iacobazzi A; Colucci A; Mininni D; Mestice A; Palumbo G
    Haematologica; 1991 Jun; 76 Suppl 3():154-7. PubMed ID: 1684339
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunohistochemical determination of glycoprotein P in 60 non-Hodgkin's lymphomas].
    Pileri S; Sabattini E; Tazzari PL; Gobbi M; Gherlinzoni F; Falini B; Baccarani M
    Haematologica; 1991 Jun; 76 Suppl 3():158-61. PubMed ID: 1684340
    [No Abstract]   [Full Text] [Related]  

  • 6. The expression of the multidrug transporter P-170 glycoprotein in remission phase is associated with early and resistant relapse in multiple myeloma.
    Musto P; Lombardi G; Matera R; Carotenuto M
    Haematologica; 1991; 76(6):513-6. PubMed ID: 1687943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.
    Flens MJ; Izquierdo MA; Scheffer GL; Fritz JM; Meijer CJ; Scheper RJ; Zaman GJ
    Cancer Res; 1994 Sep; 54(17):4557-63. PubMed ID: 7914828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
    Van Acker KL; Van Hove LM; Boogaerts MA
    Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein.
    Marquardt D; McCrone S; Center MS
    Cancer Res; 1990 Mar; 50(5):1426-30. PubMed ID: 1967979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [p170 in multiple myeloma and acute leukemia].
    Riccardi A; Invernizzi R; Ucci G; Luoni R; Danova M; Giordano M; Zambelli ML; Rastaldi MP; Ascari E
    Haematologica; 1991 Jun; 76 Suppl 3():177-80. PubMed ID: 1684345
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
    Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR
    Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance.
    Moscow JA; Cowan KH
    Cancer Chemother Biol Response Modif; 1991; 12():91-109. PubMed ID: 1681846
    [No Abstract]   [Full Text] [Related]  

  • 13. High-level expression of P-glycoprotein and 85 kD protein as assessed by flow cytometry and immunocytochemistry in leukemias and malignant lymphomas.
    Umeda Y; Tsuruo T; Mori S; Arimori S; Sugawara I
    Tokai J Exp Clin Med; 1990 May; 15(2-3):179-87. PubMed ID: 1983371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.
    Scheper RJ; Broxterman HJ; Scheffer GL; Kaaijk P; Dalton WS; van Heijningen TH; van Kalken CK; Slovak ML; de Vries EG; van der Valk P
    Cancer Res; 1993 Apr; 53(7):1475-9. PubMed ID: 7680954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies.
    Grogan T; Dalton W; Rybski J; Spier C; Meltzer P; Richter L; Gleason M; Pindur J; Cline A; Scheper R
    Lab Invest; 1990 Dec; 63(6):815-24. PubMed ID: 1979362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody C219 detection of the multidrug-resistant protein P-glycoprotein in routinely processed tissues: a study of 36 cases of ovarian carcinoma.
    Rutledge ML; Robey-Cafferty SS; Silva EG; Bruner JM
    Mod Pathol; 1990 May; 3(3):298-301. PubMed ID: 1972985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4.
    Volm M; Bak M; Efferth T; Lathan B; Mattern J
    Anticancer Res; 1988; 8(4):531-5. PubMed ID: 2902821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
    Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of drug resistance in relapsing colon cancer.
    Lazaris AC; Kavantzas NG; Zorzos HS; Tsavaris NV; Davaris PS
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):114-8. PubMed ID: 11862483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.